AGER and Cirrhosis: To the best of our insight from the accessible results, we advocate further exploitation of inflammatory signaling cascades, MAPK, and NF-κB activation as a possible target to establish a direct linkage between glycation and HCC and study the effect of the anti-RAGE antibody treatment in HCC-related cirrhosis.